Published in Am J Physiol on June 01, 1999
Targeted disruption of the murine cholecystokinin-1 receptor promotes intestinal cholesterol absorption and susceptibility to cholesterol cholelithiasis. J Clin Invest (2004) 1.18
The serotonin1A receptor: a representative member of the serotonin receptor family. Cell Mol Neurobiol (2005) 1.02
Gallbladder motor function, plasma cholecystokinin and cholecystokinin receptor of gallbladder in cholesterol stone patients. World J Gastroenterol (2005) 0.99
Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor. Br J Pharmacol (2009) 0.99
Augmented cholesterol absorption and sarcolemmal sterol enrichment slow small intestinal transit in mice, contributing to cholesterol cholelithogenesis. J Physiol (2012) 0.97
Effects of cholesterol on CCK-1 receptors and caveolin-3 proteins recycling in human gallbladder muscle. Am J Physiol Gastrointest Liver Physiol (2010) 0.97
Structural basis of cholecystokinin receptor binding and regulation. Pharmacol Ther (2008) 0.95
Association of cholecystokinin A receptor gene polymorphism with cholelithiasis and the molecular mechanisms of this polymorphism. J Gastroenterol (2002) 0.93
Differential sensitivity of types 1 and 2 cholecystokinin receptors to membrane cholesterol. J Lipid Res (2011) 0.93
Lack of cholecystokinin-A receptor enhanced gallstone formation: a study in CCK-A receptor gene knockout mice. Dig Dis Sci (2003) 0.91
A type 1 cholecystokinin receptor mutant that mimics the dysfunction observed for wild type receptor in a high cholesterol environment. J Biol Chem (2014) 0.88
Pharmacological evidence for putative CCK(1) receptor heterogeneity in human colon smooth muscle. Br J Pharmacol (2002) 0.88
Sensitivity of cholecystokinin receptors to membrane cholesterol content. Front Endocrinol (Lausanne) (2012) 0.87
Impaired Gallbladder Motility and Increased Gallbladder Wall Thickness in Patients with Nonalcoholic Fatty Liver Disease. J Neurogastroenterol Motil (2016) 0.86
Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones. Gut (2006) 0.86
Ursodeoxycholic acid improves gastrointestinal motility defects in gallstone patients. World J Gastroenterol (2006) 0.84
Expression and regulation of scavenger receptor class B type I (SR-BI) in gall bladder epithelium. Gut (2003) 0.82
Disruption of gallbladder smooth muscle function is an early feature in the development of cholesterol gallstone disease. Neurogastroenterol Motil (2012) 0.82
The systematic classification of gallbladder stones. PLoS One (2013) 0.82
Steatocholecystitis and fatty gallbladder disease. Dig Dis Sci (2008) 0.81
Cholecystokinin responsiveness varies across the population dependent on metabolic phenotype. Am J Clin Nutr (2017) 0.81
Impact of ursodeoxycholic acid on a CCK1R cholesterol-binding site may contribute to its positive effects in digestive function. Am J Physiol Gastrointest Liver Physiol (2015) 0.80
Cholelithiatic human gallbladders in vitro fail to respond to cholecystokinin but are responsive to carbachol, histamine, or electrical stimulation. Dig Dis Sci (2004) 0.79
Cholesterol gallstone disease: focusing on the role of gallbladder. Lab Invest (2014) 0.79
Beneficial effects of β-sitosterol on type 1 cholecystokinin receptor dysfunction induced by elevated membrane cholesterol. Clin Nutr (2016) 0.78
Susceptibility to obesity and gallbladder stasis produced by a protein- and fat-enriched diet in male mice compared with female mice. Nutr Metab (Lond) (2007) 0.77
Estrogen induces two distinct cholesterol crystallization pathways by activating ERα and GPR30 in female mice. J Lipid Res (2015) 0.77
High levels of caveolar cholesterol inhibit progesterone-induced genomic actions in human and guinea pig gallbladder muscle. Am J Physiol Gastrointest Liver Physiol (2009) 0.77
Age-associated gallstone formation in male and female CCK-1(A) receptor-deficient mice. J Gastroenterol (2007) 0.75
Cholecystokinin-induced satiety, a key gut servomechanism that is affected by the membrane microenvironment of this receptor. Int J Obes Suppl (2016) 0.75
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest (1999) 8.38
Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science (1999) 7.86
Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature (2001) 7.31
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet (1996) 6.43
Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science (2000) 5.62
Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med (2001) 4.71
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol (2011) 4.22
The quaking gene product necessary in embryogenesis and myelination combines features of RNA binding and signal transduction proteins. Nat Genet (1996) 3.35
Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med (1999) 3.21
BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet (1996) 2.75
Gallbladder muscle dysfunction in patients with chronic acalculous disease. Gastroenterology (2001) 2.73
Do rehabilitative nursing homes improve the outcomes of care? J Am Geriatr Soc (1996) 2.63
Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study. Ann Intern Med (1996) 2.51
Role of nonimmune IgG bound to PfEMP1 in placental malaria. Science (2001) 2.50
Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. EMBO J (1990) 2.38
Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology (2005) 2.33
The common SCN5A mutation R1193Q causes LQTS-type electrophysiological alterations of the cardiac sodium channel. J Med Genet (2004) 2.33
Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J Leukoc Biol (2000) 2.32
Osteopontin gene regulation by oscillatory fluid flow via intracellular calcium mobilization and activation of mitogen-activated protein kinase in MC3T3-E1 osteoblasts. J Biol Chem (2001) 2.27
Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins. Mol Cell Biol (1991) 2.25
Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial. Gastroenterology (1978) 2.21
Induction of alpha-synuclein aggregation by intracellular nitrative insult. J Neurosci (2001) 2.16
Small, clonally variant antigens expressed on the surface of the Plasmodium falciparum-infected erythrocyte are encoded by the rif gene family and are the target of human immune responses. J Exp Med (1999) 2.11
Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat Immunol (2001) 2.10
Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J Biol Chem (2000) 2.02
Substrate deformation levels associated with routine physical activity are less stimulatory to bone cells relative to loading-induced oscillatory fluid flow. J Biomech Eng (2000) 1.96
Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach. Ann Intern Med (1993) 1.94
Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas. J Nucl Med (1999) 1.92
KCNE1 mutations cause jervell and Lange-Nielsen syndrome. Nat Genet (1997) 1.90
Zollinger-Ellison syndrome. Clinical presentation in 261 patients. Medicine (Baltimore) (2000) 1.88
Present-day crustal deformation in China constrained by global positioning system measurements. Science (2001) 1.87
Rainforest aerosols as biogenic nuclei of clouds and precipitation in the Amazon. Science (2010) 1.86
Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study. Ann Intern Med (1989) 1.78
Integrin-mediated activation of MAP kinase is independent of FAK: evidence for dual integrin signaling pathways in fibroblasts. J Cell Biol (1997) 1.78
Localization and surgical treatment of occult insulinomas. Ann Surg (1990) 1.76
Cell anchorage permits efficient signal transduction between ras and its downstream kinases. J Biol Chem (1997) 1.75
Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nat Genet (1996) 1.74
Fresh isolates from children with severe Plasmodium falciparum malaria bind to multiple receptors. Infect Immun (2001) 1.72
Evaluation of esophageal tests in the diagnosis of reflux esophagitis. Gastroenterology (1976) 1.71
Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study. Ann Surg (1992) 1.71
Reflux esophagitis in patients with Zollinger-Ellison syndrome. Gastroenterology (1990) 1.68
IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J Clin Invest (2000) 1.66
GFI1B mutation causes a bleeding disorder with abnormal platelet function. J Thromb Haemost (2013) 1.66
High-resolution soft X-ray beamline ADRESS at the Swiss Light Source for resonant inelastic X-ray scattering and angle-resolved photoelectron spectroscopies. J Synchrotron Radiat (2010) 1.66
Synaptonemal complex antigen location and conservation. J Cell Biol (1987) 1.65
Intramural mechanics of the human tongue in association with physiological deformations. J Biomech (1999) 1.63
Assays of oxidative DNA damage biomarkers 8-oxo-2'-deoxyguanosine and 8-oxoguanine in nuclear DNA and biological fluids by high-performance liquid chromatography with electrochemical detection. Methods Enzymol (1994) 1.62
Superficial buffer barrier function of smooth muscle sarcoplasmic reticulum. Trends Pharmacol Sci (1995) 1.62
A family of human RNA-binding proteins related to the Drosophila Bruno translational regulator. J Biol Chem (2000) 1.62
Eosinophilic gastroenteritis with esophageal involvement. Gastroenterology (1977) 1.62
Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate. Vaccine (2003) 1.61
PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis. Ann Oncol (2011) 1.61
Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems? Endoscopy (2010) 1.60
Neural cell type-specific expression of QKI proteins is altered in quakingviable mutant mice. J Neurosci (1996) 1.60
Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Res (1991) 1.59
Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome. J Clin Oncol (1999) 1.59
Hypoxia inhibits the growth, differentiation and bone-forming capacity of rat osteoblasts. Exp Cell Res (2006) 1.58
A functional phosphatidylinositol 3,4,5-trisphosphate/phosphoinositide binding domain in the clathrin adaptor AP-2 alpha subunit. Implications for the endocytic pathway. J Biol Chem (1996) 1.58
Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors. Dig Dis Sci (1989) 1.57
Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S. Multicenter Study. Gastroenterology (1992) 1.57
Gastrinomas: localization by means of selective intraarterial injection of secretin. Radiology (1990) 1.56
Sensitivity analyses including and excluding the HWE-violating studies are required for meta-analyses of genetic association studies. Breast Cancer Res Treat (2009) 1.56
New mutations in the KVLQT1 potassium channel that cause long-QT syndrome. Circulation (1998) 1.53
Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas. Cancer (1999) 1.52
Turbo spin-echo diffusion-weighted MR of ischemic stroke. AJNR Am J Neuroradiol (1998) 1.50
Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies. Am J Pathol (2000) 1.50
Medical and surgical management of reflux esophagitis. A 38-month report of a prospective clinical trial. N Engl J Med (1975) 1.49
Proteolytic degradation of tyrosine nitrated proteins. Arch Biochem Biophys (2000) 1.49
Characteristics of cell lines established from human gastric carcinoma. Cancer Res (1990) 1.49
Use of omeprazole in patients with Zollinger-Ellison syndrome. Dig Dis Sci (1991) 1.49
Revision surgery for lumbar disc herniation. An analysis of 45 patients. Int Orthop (1995) 1.48
The incremental direct costs associated with behavioral symptoms in AD. Neurology (2002) 1.48
Abnormalities of gallbladder muscle associated with acute inflammation in guinea pigs. Am J Physiol Gastrointest Liver Physiol (2001) 1.48
Gastric emptying and antral motility in reflux esophagitis. Effect of oral metoclopramide. Gastroenterology (1978) 1.48
Treatment with low-dose aspirin increased the level LIF and integrin β3 expression in mice during the implantation window. Placenta (2010) 1.46
The optimal outcomes of post-hospital care under medicare. Health Serv Res (2000) 1.46
The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group. Leukemia (2009) 1.45
Effect of Cr(VI) exposure on sperm quality: human and animal studies. Ann Occup Hyg (2001) 1.45
Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome. Ann Surg (1986) 1.44
New hypothesis of chronic back pain: low pH promotes nerve ingrowth into damaged intervertebral disks. Acta Anaesthesiol Scand (2012) 1.43
Interaction of cholecystokinin with specific membrane receptors on pancreatic acinar cells. Proc Natl Acad Sci U S A (1980) 1.43
Effect of cholecystokinin and the octapeptide of cholecystokinin on the feline sphincter of Oddi and gallbladder. Mechanisms of action. J Clin Invest (1980) 1.42
Pathogenesis of simultaneous esophageal contractions in patients with motility disorders. Gastroenterology (1993) 1.42
Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome. Ann Surg (1998) 1.42
Zollinger-Ellison syndrome: current concepts and management. Ann Intern Med (1983) 1.42
Mesenchymal stem cells: a double-edged sword in regulating immune responses. Cell Death Differ (2012) 1.41
Use of post-hospital care by Medicare patients. J Am Geriatr Soc (1996) 1.41
Involvement of NF-κB/miR-448 regulatory feedback loop in chemotherapy-induced epithelial-mesenchymal transition of breast cancer cells. Cell Death Differ (2010) 1.41
Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors. Cancer Res (1998) 1.40
Interstitial photodynamic therapy in the canine prostate. Br J Urol (1997) 1.40
Cutting edge: immature dendritic cells generated from monocytes in the presence of TGF-beta 1 express functional C-C chemokine receptor 6. J Immunol (1999) 1.39
Clinical application of free digital artery flap of the hand. Plast Reconstr Surg (1999) 1.39